Omeros Corporation Plans to Test Waters with First Washington IPO in Two Years, Sources Say

Bookmark and Share

Omeros, the Seattle biotech company developing a treatment to help people recover faster from knee surgery, is preparing a renewed push for an initial public offering this fall, possibly as soon as next month, Xconomy has learned from people familiar with the matter.

Back to news